PH vs RIGL · P/E 28, rev $19.85B vs P/E 9.1, rev $179.3M
Parker-Hannifin Corporation (PH) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
PH currently screens at market cap $91.89B and trailing P/E 27.7. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the PH and RIGL stock pages for the full models.
Not investment advice.